Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Gerard Criner

Has grant

Founding Chair

Temple University

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Epidemiology Epidemiology professors in United States

Recent Grants

Grant: Open

A Randomized Double-Blind Trial to Evaluate the Efficacy and Safety of CAL101 in Patients with Idiopathic Pulmonary Fibrosis

Open Date: 2025-09-01

Close Date: 2030-09-01

Grant: Open

A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Pulmonary Disease (EMBARK)

Open Date: 2025-07-01

Close Date: 2030-07-01

Grant: Open

A Clinical Study Evaluating Temporary Transvenous Diaphragm Neurostimulation in Mechanically Ventilated Patients with Acute Hypoxemic Respiratory Failure

Open Date: 2025-07-01

Close Date: 2030-07-01

Grant: Close

Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients

Open Date: 2025-04-01

Close Date: 2026-04-01

Grant: Open

A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial evaluating the efficacy and safety of 2 doses of buloxibutid over 52 weeks in people with idiopathic pulmonary fibrosis (ASPIRE)

Open Date: 2025-03-01

Close Date: 2030-03-01

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (14)

Dirk-Jan Slebos

MD, PhD, Professor Pulmonary Diseases / Interventional Bronchoscopy

University Medical Center Groningen

NETHERLANDS

View details

Abebaw Yohannes

Professor of Physical Therapy

University of Alabama, Tuscaloosa

UNITED STATES

View details

Pallav Shah

Professor

Imperial College London

UNITED KINGDOM

View details

Christine Jenkins

Clinical Professor

University of Sydney

AUSTRALIA

View details

Marc Humbert

Professeur des Universités Praticien Hospitalier

Université Paris-Saclay

FRANCE

View details

Mehmet Kesimer

Professor

University of North Carolina

UNITED STATES

View details

Michael Gibbons

Clinical Research Lead

University of Exeter

UNITED KINGDOM

View details

Wanda O'Neal

Research Professor of Medicine and Genetics

University of North Carolina at Chapel Hill

UNITED STATES

View details

Philip L Molyneaux

Professor of Interstitial Lung Disease

Imperial College London

IRELAND

View details

Igor Barjaktarevic

University of California

UNITED STATES

View details

Antoni Torres

University of Barcelona

SPAIN

View details

ALBERTO PAPI

Full Professor of Respiratory Medicine, Head Respiratory Medicine

University of Ferrara

ITALY

View details

Jeffrey Curtis

Professor

University of Michigan

UNITED STATES

View details

Alvin Ing

Macquarie University

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gerard Criner

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (20)

The ROME COPD exacerbation proposal works! Time to move forward

Moving to better COPD care—changes to and challenges for GOLD

Metered-Dose Liquid Nitrogen Cryospray for Chronic Bronchitis: Results From the Prospective, Sham-Controlled Trial (SPRAY-CB)

Mepolizumab efficacy in chronic obstructive pulmonary disease: insights from longitudinal patterns of blood eosinophil counts and their variability across 3 clinical trials

Reply to Zheng, Zhang et al., Liu et al., Xu et al., and Zang et al.

Bronchoscopic and Surgical Interventions for Patients With COPD: A State-of-the-Art Review

Prevalence of the phenotype of lung hyperinflation and minimal emphysema in COPD

Bronchoscopic Lung Volume Reduction with Endobronchial Valves: A Consensus Statement on The Practical Aspects of Patient Selection and Periprocedural Management

Nerandomilast in Patients with Progressive Pulmonary Fibrosis.

A person-centred clinical approach to the multimorbid patient with COPD

Characteristics Associated with Lung Function Trajectories: An Analysis of the SPIROMICS Cohort.

Randomized Sham-controlled Trial of Targeted Lung Denervation in Patients with Chronic Obstructive Pulmonary Disease (AIRFLOW-3).

X-Ray Velocimetry Predicts Pneumothorax Risk after Bronchoscopic Lung Volume Reduction Using Endobronchial One-Way Valves

Emphysema detection by qualitative and quantitative analysis and relationship to spirometric obstruction in an urban comprehensive lung cancer screening programme: the Temple Healthy Chest Initiative (THCI) - a retrospective cohort study.

Management of Multifocal Benign Acquired Bronchoesophageal Fistulas.

Mechanically Affected Lung and Progression of Emphysema.

Reduction in systemic glucocorticoid utilization among COPD patients with type 2 inflammation treated with biologics.

Reply to Currow &lt;i&gt;et al.&lt;/i&gt;: Geographic Variation in Prevalence of Breathlessness: Latitude.

Respiratory Exacerbations and Lung Function Decline in People with Smoking History and Normal Spirometry.

Clinical utility of 1:16 serum dilution as a predictor of response to therapeutic plasma exchange for HLA antibody-mediated rejection treatment and overall survival in lung transplant recipients: A two center study.

Collaborators (14)

Dirk-Jan Slebos

Abebaw Yohannes

Pallav Shah

Christine Jenkins

Marc Humbert

Mehmet Kesimer

Michael Gibbons

Wanda O'Neal

Philip L Molyneaux

Igor Barjaktarevic

Antoni Torres

ALBERTO PAPI

Jeffrey Curtis

Alvin Ing

Make your next move.

Reply to Currow <i>et al.</i>: Geographic Variation in Prevalence of Breathlessness: Latitude.